55 studies found for:    Echocardiography | Open Studies | NIH, U.S. Fed
Show Display Options
Download search resultsDownload the search results for:
Echocardiography | Open Studies | NIH, U.S. Fed (55 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Unknown  Evaluating a New Echocardiography Imaging Procedure for Evaluating Heart Function
Conditions: Ischemia;   Myocardial Infarction;   Ischemic Heart Disease
Intervention:
2 Recruiting Fetal and Neonatal Magnetophysiology
Conditions: Fetal Arrhythmia;   Fetal Heart Rate;   Long QT Syndrome
Interventions: Device: magnetocardiography;   Device: postnatal ECG;   Device: fetal echocardiography
3 Recruiting New Techniques to Evaluate Mitral Regurgitation
Condition: Mitral Valve Regurgitation
Intervention:
4 Recruiting Brain Integrity in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation
Condition: Hodgkin Lymphoma
Interventions: Other: Neurocognitive Evaluation;   Device: Quantitative Brain Imaging;   Other: Neurologic Evaluation;   Other: Health Questionnaire;   Device: Vascular Testing;   Device: Cardiopulmonary Exercise Testing;   Device: Echocardiography;   Device: Pulmonary Function Testing;   Procedure: Serum Biomarkers;   Other: Ophthalmology Examination
5 Recruiting Health Effects After Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-related Cardiomyopathy
Conditions: T-cell Acute Lymphoblastic Leukemia;   Intermediate Hodgkins;   Advanced Hodgkins;   Early Hodgkins
Interventions: Other: Diagnostic/symptom checklist;   Other: Anthropometry;   Procedure: Echocardiogram;   Procedure: Serum Biomarkers;   Other: 6 minute walk test (6MWT);   Behavioral: Participant Questionnaires (ages ≥14 years only)
6 Recruiting Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia
Conditions: Pulmonary Hypertension;   Sickle Cell Anemia
Intervention:
7 Unknown  Validation of Minimally Invasive Ultrasound Indicator Dilution Technique in Critically Ill Children
Condition: Cardiac Output
Intervention:
8 Recruiting Alemtuzumab (Campath ) to Treat T-Large Granular Lymphocyte Leukemia
Condition: Lymphoproliferative Disorders
Intervention: Drug: Alemtuzumab (Campath)
9 Recruiting Cardiovascular Disease Screening
Conditions: Congenital Heart Disease;   Atherosclerosis;   Myocardial Ischemia;   Myocardial Infarction;   Acquired Heart Disease
Intervention:
10 Recruiting Alemtuzumab to Treat Severe Aplastic Anemia
Conditions: Relapsed or Refractory Severe Aplastic Anemia;   Severe Aplastic Anemia
Intervention: Drug: Alemtuzumab (Campath )
11 Recruiting Natural History of Sickle Cell Disease and Other Hemolytic Disorders
Conditions: Hemoglobin SC Disease;   Hematologic Diseases;   Sickle Cell Anemia;   Hemolytic Anemia
Intervention:
12 Recruiting Evaluation of Patients With Heart Disease Not Eligible for Research Protocols
Condition: Heart Disease
Intervention:
13 Recruiting Study to Evaluate the Safety and Activity of BB3 to Treat Heart Attack
Condition: Myocardial Infarction
Interventions: Drug: BB3;   Drug: Placebo
14 Recruiting Evaluation of Primary Chronic Autonomic Failure
Condition: Autonomic Nervous System Diseases
Intervention:
15 Recruiting ClinSeq: A Large-Scale Medical Sequencing Clinical Research Pilot Study
Conditions: Cardiovascular Disease;   Coronary Artery Calcification
Intervention:
16 Recruiting Role of p53 Gene in Metabolism Regulation in Patients With Li-Fraumeni Syndrome
Condition: Li-Fraumeni Syndrome
Intervention:
17 Recruiting Galectin-3 Blockade in Patients With High Blood Pressure
Condition: Hypertension
Intervention: Dietary Supplement: Modified Citrus Pectin (MCP)
18 Recruiting Identification of Patient Phenotypes Associated With Elevated Aldosterone Levels
Condition: Acute Heart Failure
Intervention:
19 Recruiting AC6 Gene Transfer for CHF
Condition: Congestive Heart Failure
Interventions: Drug: Ad5.hAC6;   Drug: Sucrose (3%)
20 Recruiting Spironolactone in Adult Congenital Heart Disease
Conditions: Congenital Heart Disease;   Heart Failure;   Endomyocardial Fibrosis
Interventions: Drug: Spironolactone;   Other: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years